Skip to Content
Merck
CN
  • A Drosophila model of diabetic neuropathy reveals a role of proteasome activity in the glia.

A Drosophila model of diabetic neuropathy reveals a role of proteasome activity in the glia.

iScience (2023-06-28)
Mari Suzuki, Hiroshi Kuromi, Mayumi Shindo, Nozomi Sakata, Naoko Niimi, Koji Fukui, Minoru Saitoe, Kazunori Sango
ABSTRACT

Diabetic peripheral neuropathy (DPN) is the most common chronic, progressive complication of diabetes mellitus. The main symptom is sensory loss; the molecular mechanisms are not fully understood. We found that Drosophila fed a high-sugar diet, which induces diabetes-like phenotypes, exhibit impairment of noxious heat avoidance. The impairment of heat avoidance was associated with shrinkage of the leg neurons expressing the Drosophila transient receptor potential channel Painless. Using a candidate genetic screening approach, we identified proteasome modulator 9 as one of the modulators of impairment of heat avoidance. We further showed that proteasome inhibition in the glia reversed the impairment of noxious heat avoidance, and heat-shock proteins and endolysosomal trafficking in the glia mediated the effect of proteasome inhibition. Our results establish Drosophila as a useful system for exploring molecular mechanisms of diet-induced peripheral neuropathy and propose that the glial proteasome is one of the candidate therapeutic targets for DPN.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-DNAJA1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Trehalase from porcine kidney, buffered aqueous glycerol solution, ≥1.0 units/mg protein
Sigma-Aldrich
Insulin solution human, sterile-filtered, BioXtra, suitable for cell culture